Targeting co-stimulatory molecules in autoimmune disease

NM Edner, G Carlesso, JS Rush… - Nature Reviews Drug …, 2020 - nature.com
Therapeutic targeting of immune checkpoints has garnered significant attention in the area
of cancer immunotherapy, in which efforts have focused in particular on cytotoxic T …

The TNF receptor superfamily in co-stimulating and co-inhibitory responses

LK Ward-Kavanagh, WW Lin, JR Šedý, CF Ware - Immunity, 2016 - cell.com
Cytokines related to tumor necrosis factor (TNF) provide a communication network essential
for coordinating multiple cell types into an effective host defense system against pathogens …

Survivin: a unique target for tumor therapy

H Garg, P Suri, JC Gupta, GP Talwar, S Dubey - Cancer cell international, 2016 - Springer
Survivin is the smallest member of the Inhibitor of apoptosis (IAP) family of proteins, involved
in inhibition of apoptosis and regulation of cell cycle. These functional attributes make …

T follicular helper cell heterogeneity: time, space, and function

W Song, J Craft - Immunological reviews, 2019 - Wiley Online Library
T follicular helper (Tfh) cells play a crucial role in orchestrating the humoral arm of adaptive
immune responses. Mature Tfh cells localize to follicles in secondary lymphoid organs (SLO …

The role of TNF superfamily members in T-cell function and diseases

M Croft - Nature Reviews Immunology, 2009 - nature.com
Interactions that occur between several tumour necrosis factor (TNF)–TNF receptors that are
expressed by T cells and various other immune and non-immune cell types are central to T …

Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin

S Colombetti, V Basso, DL Mueller… - The Journal of …, 2006 - journals.aai.org
Proliferation of Ag-specific T cells is central to the development of protective immunity. The
concomitant stimulation of the TCR and CD28 programs resting T cells to IL-2-driven clonal …

The significance of OX40 and OX40L to T‐cell biology and immune disease

M Croft, T So, W Duan, P Soroosh - Immunological reviews, 2009 - Wiley Online Library
OX40 (CD134) and its binding partner, OX40L (CD252), are members of the tumor necrosis
factor receptor/tumor necrosis factor superfamily and are expressed on activated CD4+ and …

OX40 agonists and combination immunotherapy: putting the pedal to the metal

SN Linch, MJ McNamara, WL Redmond - Frontiers in oncology, 2015 - frontiersin.org
Recent studies have highlighted the therapeutic efficacy of immunotherapy, a class of
cancer treatments that utilize the patient's own immune system to destroy cancerous cells …

Control of immunity by the TNFR-related molecule OX40 (CD134)

M Croft - Annual review of immunology, 2009 - annualreviews.org
TNFR/TNF superfamily members can control diverse aspects of immune function. Research
over the past 10 years has shown that one of the most important and prominent interactions …

Agonists of co-stimulation in cancer immunotherapy directed against CD137, OX40, GITR, CD27, CD28, and ICOS

MF Sanmamed, F Pastor, A Rodriguez… - Seminars in …, 2015 - Elsevier
T and natural killer (NK) lymphocytes are considered the main effector players in the
immune response against tumors. Full activation of T and NK lymphocytes requires the …